Cotazym and Lipitor drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cotazym (pancrelipase (amylase;lipase;protease)) and Lipitor (atorvastatin calcium). Common drug interactions include abdominal hernia among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Cotazym and Lipitor. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Cotazym?
Cotazym has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 377 Cotazym users. Check the latest studies of Cotazym.
What is Lipitor?
Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.
14 people who take Cotazym and Lipitor together, and have interactions are studied.

What are the common drug interactions of Cotazym and Lipitor, by gender? *:
female:
- Abdominal hernia
- Arthralgia (joint pain)
- Body temperature increased
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
male:
- Abdominal pain
- Back pain
- Breast pain
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Drug ineffective
- Gynaecomastia (enlargement of the gland tissue of the male breast)
- Nasopharyngitis (inflammation of the nasopharynx)
- Blood glucose increased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Constipation
What are the common drug interactions of Cotazym and Lipitor, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abdominal pain
- Back pain
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Constipation
- Gait disturbance
- Headache (pain in head)
- Pain
- Weight increased
- Acute sinusitis
- Blood pressure decreased
50-59:
- Blood pressure systolic increased
- Body temperature decreased
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
- Breast mass
- Breast pain
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Drug ineffective
- Gynaecomastia (enlargement of the gland tissue of the male breast)
- Headache (pain in head)
- Injection site pain
60+:
- Abdominal hernia
- Death
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Impaired healing
- Wound dehiscence (a surgical incision reopens either internally or externally)
What are the existing conditions these people have? *
- Dumping Syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight): 6 people, 42.86%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 21.43%
- Osteoporosis (bones weak and more likely to break): 3 people, 21.43%
- Constipation: 3 people, 21.43%
- Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 14.29%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 14.29%
- Breakthrough Pain: 2 people, 14.29%
- Cardiac Disorder: 2 people, 14.29%
- Depression: 2 people, 14.29%
- Diarrhea: 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Cotazym and Lipitor?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cotazym and Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cotazym:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cotazym and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lipitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and atorvastatin calcium (the active ingredients of Cotazym and Lipitor, respectively), and Cotazym and Lipitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Copegus and Dilantin - now
- Drug interactions of Intron A and Tamsulosin Hydrochloride - 9 seconds ago
- Could Sumatriptan cause Cough? - 12 seconds ago
- Antiviral and Back Pain Aggravated - 19 seconds ago
- Drug interactions of Methocarbamol and Cimzia - 19 seconds ago
- Could Slow-K cause Traumatic Injury Of The Bladder And Urethra? - 23 seconds ago
- Ankylosing Spondylitis and Injection Site Rash - 25 seconds ago
- Gallstones and Ascites - 27 seconds ago
- Could Skyrizi cause Non-Hodgkin'S Lymphoma? - 31 seconds ago
- Drug interactions of Oxybutynin Chloride and Folate - 41 seconds ago